Post-approval studies (Phase 4)Study completedNCT00190892What this trial is testingOlanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaWho this might be right forBipolar Disorder Eli Lilly and Company 120
Large-scale testing (Phase 3)Study completedNCT01349907What this trial is testingExtension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)Who this might be right forBipolar Disorder Organon and Co 322
Large-scale testing (Phase 3)Study completedNCT03259555What this trial is testingA Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I DisorderWho this might be right forBipolar I DisorderManic Episode Otsuka Pharmaceutical Development & Commercialization, Inc. 322
Large-scale testing (Phase 3)Study completedNCT00309686What this trial is testingEvaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I DisorderWho this might be right forAffective Psychosis, BipolarBipolar DisorderMania Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 300
Large-scale testing (Phase 3)Study completedNCT00266630What this trial is testingEfficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I DisorderWho this might be right forManic or Mixed Episode Associated With Bipolar I Disorder Eli Lilly and Company 139
Large-scale testing (Phase 3)Study completedNCT00249236What this trial is testingThe Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderWho this might be right forBipolar DisorderManic Episode Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291
Testing effectiveness (Phase 2)Looking for participantsNCT07046494What this trial is testingStudy Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderWho this might be right forBipolar 1 Disorder Rapport Therapeutics Inc. 224
Large-scale testing (Phase 3)Study completedNCT06419582What this trial is testingBHV-7000 Acute Treatment of Bipolar ManiaWho this might be right forBipolar Disorder Biohaven Therapeutics Ltd. 274
Large-scale testing (Phase 3)Study completedNCT04819776What this trial is testingEvaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderWho this might be right forBipolar I Disorder Vanda Pharmaceuticals 417
Large-scale testing (Phase 3)Study completedNCT03257865What this trial is testingA Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I DisorderWho this might be right forBipolar I DisorderManic Episode Otsuka Pharmaceutical Development & Commercialization, Inc. 333
Large-scale testing (Phase 3)Study completedNCT01244815What this trial is testingEfficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)Who this might be right forBipolar Disorder, Pediatric Organon and Co 404
Large-scale testing (Phase 3)Study completedNCT00129220What this trial is testingTrial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I DisorderWho this might be right forBipolar Disorder Eli Lilly and Company 224
Large-scale testing (Phase 3)Looking for participantsNCT06462612What this trial is testingStudy of Lumateperone in the Treatment of Patients With Bipolar ManiaWho this might be right forBipolar Disorder, Manic Intra-Cellular Therapies, Inc. 350
Large-scale testing (Phase 3)Study completedNCT00490971What this trial is testingEvaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I DisorderWho this might be right forBipolar Disorder Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768
Large-scale testing (Phase 3)Looking for participantsNCT06462586What this trial is testingStudy of Lumateperone in the Acute Treatment of Patients With Bipolar ManiaWho this might be right forBipolar Disorder, Manic Intra-Cellular Therapies, Inc. 350